Stockscreener 앱 받기
7.65
2.41%
0.18
시간 외 거래:
7.65
Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스
Fennec Pharmaceuticals (TSX:FRX) Shares Drift Below Key Average Level - Kalkine Media
Fennec Pharma (TSX:FRX) Falls Below Key Average in TSX Index - Kalkine Media
Fennec Pharmaceuticals (TSE:FRX) Shares Cross Below 50 Day Moving AverageTime to Sell? - MarketBeat
Retail Surge: Is Fennec Pharmaceuticals Inc still a buy after recent gains2026 Big Picture & Reliable Trade Execution Plans - baoquankhu1.vn
Breakout Zone: Can Fennec Pharmaceuticals Inc stock outperform in a bear marketTrend Reversal & Long-Term Capital Growth Ideas - baoquankhu1.vn
Fennec to Report 2025 Results as Global Rollout of PEDMARK Advances - TipRanks
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026 - The Manila Times
Fennec Pharmaceuticals Inc. - Mena FN
Cipla To Hold Off On Pediatric Cancer Drug Generic Until 2033 - Law360
B Riley Reaffirms Fennec's Buy Rating, US$16.00 Price Target After Cipla Settlement - marketscreener.com
FENC Stock Quote - RichTv
Fennec Pharmaceuticals (FENC) delays Cipla generic PEDMARK rival until 2033 - Stock Titan
Fennec Pharmaceuticals announces settlement agreement resolving Pedmark patent litigation - marketscreener.com
Fennec settles patent case with Cipla over generic PEDMARK - Investing.com
Fennec Pharmaceuticals Announces Settlement Agreement Resolving Pedmark Patent Litigation - TradingView
Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation - The Manila Times
Patent deal delays PEDMARK generic, drug for chemo hearing loss, to 2033 - Stock Titan
(FRX) Technical Patterns and Signals (FRX:CA) - Stock Traders Daily
Adherex Technologies (NASDAQ:FENC) Cut to Buy at Wall Street Zen - MarketBeat
Liquidity Mapping Around (FENC) Price Events - Stock Traders Daily
(FRX) Market Insights and Trading Signals (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals Hits Day Low of CAD 10.35 Amid Price Pressure - Markets Mojo
Adolescent cancer patients face unique survivorship hurdles, Fennec Pharmaceuticals asserts - Traders Union
Fennec Pharmaceuticals Announces Clinical Research Collaboration With Tampa General Hospital Cancer Institute - Florida Hospital News and Healthcare Report
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Will Fennec Pharmaceuticals Inc. stock maintain growth story2025 Sector Review & Fast Exit and Entry Strategy Plans - Naître et grandir
Can Fennec Pharmaceuticals Inc sustain earnings growth2025 Bull vs Bear & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Fennec Pharmaceuticals (TSX:FRX) Moves Higher on Renewed Trading Focus - Kalkine Media
Aug Chart Watch: Does Fennec Pharmaceuticals Inc outperform in volatile marketsJuly 2025 Big Picture & Daily Volume Surge Signals - baoquankhu1.vn
Fennec Pharmaceuticals (TSE:FRX) Shares Cross Above 50-Day Moving AverageWhat's Next? - MarketBeat
Fennec Pharmaceuticals Inc expected to post earnings of 4 cents a shareEarnings Preview - TradingView
Earnings Preview: Gossamer Bio (GOSS) Q4 Earnings Expected to Decline - Finviz
Fennec, Tampa General launch real-world PEDMARK oncology study - TipRanks
Fennec (FENC) backs PEDMARK real-world study at Tampa General - Stock Titan
Dow Update: Why is Fennec Pharmaceuticals Inc stock going downJuly 2025 Breakouts & Fast Moving Stock Trade Plans - baoquankhu1.vn
Stocks in play: Fennec Pharmaceuticals Inc. - Barchart.com
Fennec Pharmaceuticals Collaborates With TGH Cancer Institute for Pedmark Study - marketscreener.com
Fennec Pharmaceuticals Inc. and Tampa General Hospital Cancer Institute Initiate Clinical Research Collaboration - marketscreener.com
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute - GlobeNewswire
Fennec (NASDAQ: FENC) CFO acquires 1,191 common shares via award vesting - Stock Titan
Fennec Pharmaceuticals (FENC) director trades options and common shares - Stock Titan
Why (FENC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
FENC (NASDAQ: FENC) insider files to sell 10,079 shares via option exercise - Stock Titan
Adherex Technologies Inc. (FENC) Earnings Expected to Grow: What to Know Ahead of Q4 Release - Finviz
FENC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Adherex Technologies (FENC) to Release Quarterly Earnings on Monday - MarketBeat
FENC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
FENC Should I Buy - Intellectia AI
FENC SEC FilingsFennec Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Public market insider buying at Fennec Pharmaceuticals (FRX) - The Globe and Mail
(FRX) Investment Analysis and Advice (FRX:CA) - Stock Traders Daily
Quarterly Trades: Is ZVIA stock forming a cup and handleTrade Volume Report & Technical Pattern Alert System - baoquankhu1.vn
Portfolio Update: Can Fennec Pharmaceuticals Inc stock outperform in a bear marketEarnings Risk Summary & Fast Moving Stock Watchlists - baoquankhu1.vn
Chipmakers Recap: Why is Fennec Pharmaceuticals Inc stock going down2025 Risk Factors & Precise Buy Zone Identification - baoquankhu1.vn
(FRX) Advanced Equity Analysis (FRX:CA) - Stock Traders Daily
Will Fennec Pharmaceuticals Inc. stock benefit from upcoming earnings reportsWeekly Investment Report & Fast Gaining Stock Strategy Reports - mfd.ru
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Fennec Pharmaceuticals (FENC) and InfuSystem Holdings (INFU) - The Globe and Mail
Fennec Pharmaceuticals presents real-world data showing PEDMARK feasible, well tolerated in adults with head & neck cancer - TradingView
New PEDMARK real-world data in adult head & neck cancer from Fennec (NASDAQ: FENC) - Stock Titan
Is Fennec Pharmaceuticals Inc. still a buy after recent gainsRecession Risk & Advanced Swing Trade Entry Plans - mfd.ru
Fennec Showcases Real-World Data Backing PEDMARK Use in Adult Head and Neck Cancer - TipRanks
Fennec Pharmaceuticals Inc. Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK®? in Treating Adults with Head & Neck Cancers - marketscreener.com
Cancer drug timing tweak shows promise for preserving hearing - Stock Titan
Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK® in Treating Adults with Head & Neck Cancers - Yahoo Finance
Fennec Pharmaceuticals (FENC) CEO granted 13,710 shares as PSUs vest - Stock Titan
Fennec (NASDAQ: FENC) CFO adds shares via option exercise and PSU vesting - Stock Titan
(FRX) Investment Performance Report (FRX:CA) - Stock Traders Daily
When the Price of (FRX) Talks, People Listen (FRX:CA) - Stock Traders Daily
1.20%
0.06%
자본화:
|
볼륨(24시간):